Evidence map›Paper›PMID 35744915›Full record

ArticleMolecules (Basel, Switzerland)2022

Therapeutic Effect of Renifolin F on Airway Allergy in an Ovalbumin-Induced Asthma Mouse Model In Vivo.

Zhuya Yang, Xiaohong Li, Rongbing Fu, Min Hu, Yijie Wei, Xuhong Hu, Wenhong Tan, Xiaoyun Tong, Feng Huang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zhuya YangKey Laboratory of Yunnan Provincial Department of Education on Substance Benchmark Research of Ethnic Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.
Xiaohong LiKey Laboratory of Yunnan Provincial Department of Education on Substance Benchmark Research of Ethnic Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.
Rongbing FuKey Laboratory of Yunnan Provincial Department of Education on Substance Benchmark Research of Ethnic Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.
Min HuKey Laboratory of Yunnan Provincial Department of Education on Substance Benchmark Research of Ethnic Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.
Yijie WeiKey Laboratory of Yunnan Provincial Department of Education on Substance Benchmark Research of Ethnic Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.
Xuhong HuKey Laboratory of Yunnan Provincial Department of Education on Substance Benchmark Research of Ethnic Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.
Wenhong TanKey Laboratory of Yunnan Provincial Department of Education on Substance Benchmark Research of Ethnic Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.
Xiaoyun TongThe First Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650021, China.ORCID 0000-0002-8722-4706
Feng HuangKey Laboratory of Yunnan Provincial Department of Education on Substance Benchmark Research of Ethnic Medicines, Yunnan University of Chinese Medicine, Kunming 650500, China.ORCID 0000-0002-8741-4219
Yunnan University · CN

Funding

the Key project of Yunnan provincial science and technology department 2019FA035the Middle-Aged Academic and Technical Leaders of Yunnan Province 202205AC160039the National Natural Science Foundation of China 81960778the National Natural Science Foundation of China 82060751Yunnan Innovation Team of Application Research on TCM Theory of Prevention Disease at Yunnan University of TCM 2017HC011Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Chinese Medicine 2019FF002-009
6 · The paper itself

Abstract

Renifolin F is a prenylated chalcone isolated from

Indexed as

AsthmaHypersensitivityMicroRNAsAnimalsBronchoalveolar Lavage FluidChalconeCytokinesDisease Models, AnimalImmunity, InnateInflammationLungLymphocytesMiceOvalbuminChalconeCytokinesMicroRNAsMirn155 microRNA, mouseOvalbuminairway inflammationallergic asthmaILC2sovalbumin (OVA)Renifolin FShuteria involucrata (Wall.) Wight & Arn.

Identifiers

PMID35744915
PMCPMC9227769
OpenAlexW4282569745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.